NEURODERMATITIS
Clinical trials for NEURODERMATITIS explained in plain language.
Never miss a new study
Get alerted when new NEURODERMATITIS trials appear
Sign up with your email to follow new studies for NEURODERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shockwaves soothe skin: new hope for neurodermatitis itch?
Symptom relief CompletedThis study tested whether a treatment called extracorporeal shockwave therapy can reduce itching in people with neurodermatitis, a chronic skin condition. 34 adults aged 55 to 75 took part. Researchers measured itch severity before and after treatment using a standard scale. The …
Matched conditions: NEURODERMATITIS
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated May 17, 2026 14:59 UTC
-
New hope for chronic itch sufferers: drug shows promise in clinical trial
Symptom relief CompletedThis study tested a drug called dupilumab in 151 adults with prurigo nodularis, a skin condition causing intense itching and bumps. Participants had severe itch not controlled by prescription creams. The goal was to see if dupilumab could reduce itch and clear skin lesions. Resul…
Matched conditions: NEURODERMATITIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated May 17, 2026 14:55 UTC
-
New hope for relentless itch: drug cuts suffering in half
Symptom relief CompletedThis study tested a medicine called dupilumab in 160 adults with prurigo nodularis, a skin condition that causes intense itching and hard bumps. Participants had severe itch that wasn't helped by prescription creams. The goal was to see if dupilumab could reduce itching and clear…
Matched conditions: NEURODERMATITIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC